Martin Schönlein

23PUBLICATIONS
261CO-AUTHORS
Haematological tumoursRespiratory diseasesPredictive and prognostic markersCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 04, 2026
Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity.

|Dec 23, 2024
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.

Jon Salmanton-García, Francesco Marchesi, Milan Navrátil

|Nov 28, 2024
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity.

Anais Elewaut, Guillem Estivill, Felix Bayerl

|Nov 27, 2023
EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma.

Lorenz Kocheise, Martin Schoenlein, Berit Behrends

|Nov 15, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.

Shaimaa El-Ashwah, Jon Salmanton-García, Yavuz M Bilgin

|Oct 27, 2023
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.

Vincent Joerg, Bernhard Scheiner, Antonio D Alessio

Pageof 4

Frequent Collaborators

11 joint publications

Francesco Marchesi

11 joint publications

Jon Salmanton-García

11 joint publications

Livio Pagano

9 joint publications

Andreas Glenthøj